Home › Funds › Defilade Capital Management, L.P. › TYRA
Defilade Capital Management, L.P. position in TYRA
TYRA BIOSCIENCES INC COM · Health Care
Defilade Capital Management, L.P. reported holding 376,870 shares of TYRA (TYRA BIOSCIENCES INC COM) in its Q2 2026 13F filing — a position valued at US$12.0M, representing 1.61% of its reported portfolio and ranking #24 among its reported holdings. Defilade Capital Management, L.P. first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Defilade Capital Management, L.P.'s TYRA position evolved
Defilade Capital Management, L.P. first disclosed a stake in TYRA in Q2 2026 at 376,870 shares (US$12.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 376.87K | $12.04M | New |
About TYRA and 13F data
TYRA (TYRA BIOSCIENCES INC COM) is a Health Care company. 57 other funds we track also report a position in TYRA — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$389.6M), Alta Partners Management Company, L.P. (US$122.1M), Nextech Invest Ltd. (US$113.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TYRA
- RA CAPITAL MANAGEMENT, L.P. 12.20M sh · $389.62M · Q2 2026
- Alta Partners Management Company, L.P. 3.82M sh · $122.12M · Q2 2026
- Nextech Invest Ltd. 3.55M sh · $113.50M · Q2 2026
- TCG Crossover Management, LLC 3.25M sh · $103.77M · Q2 2026
- Commodore Capital LP 1.88M sh · $59.89M · Q2 2026
- Paradigm Biocapital Advisors LP 1.83M sh · $58.41M · Q2 2026
- BVF INC/IL 1.48M sh · $47.15M · Q2 2026
- 5AM Venture Management, LLC 1.03M sh · $32.88M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.02M sh · $32.48M · Q2 2026
- Caligan Partners LP 806.99K sh · $25.78M · Q2 2026
- Canaan Partners XI LLC 750.00K sh · $23.95M · Q2 2026
- Sio Capital Management, LLC 695.32K sh · $22.21M · Q2 2026
More on Defilade Capital Management, L.P.
FAQ
How long has Defilade Capital Management, L.P. held TYRA?
Defilade Capital Management, L.P. has disclosed TYRA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Defilade Capital Management, L.P.'s current position in TYRA?
As of Q2 2026, Defilade Capital Management, L.P. holds 376.87K shares of TYRA (TYRA BIOSCIENCES INC COM), valued at $12.04M, representing 1.61% of its reported portfolio and ranking #24.
Has Defilade Capital Management, L.P. been buying or selling TYRA?
In the latest 13F filing (Q2 2026), Defilade Capital Management, L.P. newly opened its position in TYRA.
Which other funds hold TYRA?
Other major institutional holders of TYRA include RA CAPITAL MANAGEMENT, L.P., Alta Partners Management Company, L.P., Nextech Invest Ltd., among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.